In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 1204 for your search:
Drug:  cytarabine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004

2.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 16 to 60
Sponsor: Other
Protocol IDs: MK1-95, NCT00180102

3.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 60 and over
Sponsor: Other
Protocol IDs: AML_GT60_DD, NCT00180167

4.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20050100, NCT00352703

5.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 65 and under
Sponsor: Other
Protocol IDs: AML99<=65 años, NCT00390715

6.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: SHEBA-06-4196-MKM-CTIL, NCT00449592

7.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2006-003750-23, LINFOTARGAM, NCT00466258

8.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: Other
Protocol IDs: LAL-RI/96, NCT00494897

9.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 65 and under
Sponsor: Other
Protocol IDs: LAL-Ph-2000, NCT00526305

10.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-00055-18, NCT00415103

11.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Any age
Sponsor: Other
Protocol IDs: PETHEMA-LAM07, NCT01041040

12.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: RJ-2010-56, NCT01358253

13.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 16 to 65
Sponsor: Other
Protocol IDs: HDE-ALL-2011, NCT01457040

14.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 15 to 60
Sponsor: Other
Protocol IDs: AML-01.10, NCT01587430

15.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PDL-3-251, MSKCC-93131, NCI-V94-0469

16.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21 at relapse
Sponsor: NCI
Protocol IDs: POG-9410, POG-SIMAL-8

17.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 18
Sponsor:
Protocol IDs: SJCRH-ALL-TT-8

18.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 60
Sponsor:
Protocol IDs: NCI-D81-018-590, DFCI-80035

19.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D82-018-544, DFCI-80051, DFCI-CML

20.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: NCI-D82-051-605

21.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: CCG-192P

22.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: physiologic 70 and under
Sponsor: NCI
Protocol IDs: RPMI-PPC-744, NCI-T83-0960D

23.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 60
Sponsor:
Protocol IDs: EORTC-LAM-4

24.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: NCI-85-C-62, NCI-T85-0096N, T85-0096

25.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-81001, NCI-D82-018-0400, D82-018-0400
1     
New Search